The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
- 16 October 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 497, 77-88
- https://doi.org/10.1016/j.canlet.2020.10.022
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (2017N8CK4K, PE-2016-02361797)
- Associazione Italiana per la Ricerca sul Cancro (IG 2017–20594)
This publication has 46 references indexed in Scilit:
- Analysis of the Role of Igf2 in Adrenal Tumour Development in Transgenic Mouse ModelsPLOS ONE, 2012
- Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in miceMolecular Cancer, 2012
- Human adrenocortical carcinoma cell linesMolecular and Cellular Endocrinology, 2012
- The filaminsCell Adhesion & Migration, 2011
- Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in CancerMolecular Cancer Therapeutics, 2010
- Filamin A Modulates Kinase Activation and Intracellular Trafficking of Epidermal Growth Factor Receptors in Human Melanoma CellsEndocrinology, 2009
- Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical CarcinomaJournal of Clinical Endocrinology & Metabolism, 2009
- Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsCancer Cell, 2004
- Interaction of Filamin A with the Insulin Receptor Alters Insulin-dependent Activation of the Mitogen-activated Protein Kinase PathwayOnline Journal of Public Health Informatics, 2003
- Actin-Binding Protein Requirement for Cortical Stability and Efficient LocomotionScience, 1992